# Amal share price today (Amal Ltd, NSE: AMAL)

> Amal share price today: ₹574.70 at the NSE close on 4 November 2026, down 19.2% in a year. Amal (NSE: AMAL) is worth ₹709 crore, trades at a P/E of 23.8 and has closed between ₹441.65 and ₹776.25 over the past 52 weeks. > Amal Ltd's results are improving, while its P/E is near the low end of its own history over 5.8 years, higher than only 12% of past readings. AMAL · Speciality Chemicals · data as of 4 November 2026. Page: https://www.sectoralpha.in/stocks/amal-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Growing steadily, from fewer quarters than usual
- Price: ₹574.70 (−19.2% in a year)
- P/E: 23.8× (lower than 88% of the last 5.8 years)
- Revenue (Sep 2026): ₹131 Cr (+143.0% on a year ago)
- Profit (Sep 2026): ₹6.2 Cr (+1.7% on a year ago)
- Operating margin: 6.5% (−9.5 points on a year ago)
- ROCE: 26%, FY26
- ROIC: 29.3%, against a 12.0% cost of capital: +17.3 points

Biggest thing to watch: the price has already been rising for 14 weeks, so timing is the risk more than the business. ## What is the Amal share price today? Amal Ltd's share price was ₹574.70 at the close on 4 November 2026. It has been rising for 14 weeks. That is 14.0% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹442 and ₹776, and at that close it sat 40% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 3 weeks running. Over the last 11 years the share price moved +2,202% while the NIFTY 500 moved +251%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 16 October 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Amal this quarter? Three changes stood out: revenue up on a year earlier for 12 quarters in a row (every quarter we can compare), lowest operating margin in 13 quarters and highest quarterly revenue in 16 quarters. 1. Revenue up on a year earlier for 12 quarters in a row (every quarter we can compare) In the September 2026 quarter revenue was ₹131 crore, +143% on a year earlier. 2. Lowest operating margin in 13 quarters Operating margin was 6.5% in the September 2026 quarter, against 15.9% a year earlier. 3. Highest quarterly revenue in 16 quarters Revenue of ₹131 crore in the September 2026 quarter is the highest of the last 16 quarters. ## What are Amal's latest quarterly results? For July to September 2026 (the quarter ended 30 September 2026), Amal reported revenue of ₹131 crore, up 143.0% from ₹54.0 crore a year earlier, and a profit of ₹6.16 crore, up 1.7% from ₹6.06 crore. ### Amal results: July to September 2026 against a year earlier

| Measure | July to September 2026 | July to September 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹131 crore | ₹54.0 crore | +143.0% |
| Profit | ₹6.16 crore | ₹6.06 crore | +1.7% |
| Earnings per share | ₹4.98 | ₹4.90 | +1.6% |
| Operating margin | 6.5% | 15.9% | −9.5 points |

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). (From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.)

## What is the Amal share price history? Amal closed at ₹574.70 on 4 November 2026, down 19.2% from ₹711.40 a year earlier (7 November 2025) and up 56.2% over five years. Its highest weekly close since March 2016 was ₹1,044.90 on 25 July 2025. ### Amal share price: then and now

| When | Close | Change to 4 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 30 Oct 2026 | ₹533.50 | +7.7% |
| 1 month ago · 1 Oct 2026 | ₹699.85 | −17.9% |
| 1 year ago · 7 Nov 2025 | ₹711.40 | −19.2% |
| 3 years ago · 3 Nov 2023 | ₹328.15 | +75.1% |
| 5 years ago · 4 Nov 2021 | ₹368.03 | +56.2% |
| 10 years ago · 4 Nov 2016 | ₹74.16 | +674.9% |
| Earliest and lowest weekly close in our records · 11 Mar 2016 | ₹24.96 | +2,202.5% |
| Highest weekly close since March 2016 · 25 Jul 2025 | ₹1,044.90 | −45.0% |
| 52-week high (weekly close) · 21 Aug 2026 | ₹776.25 | −26.0% |
| 52-week low (weekly close) · 27 Mar 2026 | ₹441.65 | +30.1% |

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (543 weekly closes from 11 March 2016 to 4 November 2026.)

## What is the latest news on Amal? 4 Nov 2026: Amal closed at ₹574.70, up 7.7% on the week and down 17.9% on the month. Results for July to September 2026: Revenue up 143.0% and profit up 1.7% on a year earlier. ## What dividend does Amal pay? The NSE corporate-actions record has no dividend for Amal since 1 April 2021, so this page cannot show amounts per share. Yes. Amal Ltd paid out 8% of its profit as dividends in FY26, and it paid a dividend in 2 of its last 7 reported years. (From the NSE corporate-actions record, read 5 November 2026.)

## Which stock lists is Amal on? Amal is not on any of our India lists this week. ## Is Amal profitable? Amal Ltd earned ₹6.2 Cr of net profit in the Sep 2026 quarter, +1.7% on the same quarter a year earlier. That is the 2nd quarter in a row of profit growth. Full-year FY26 profit was ₹22.0 Cr. Over 6 years profit has grown 16.1% a year on average. That is 4.7% of the quarter's revenue. The same quarter a year earlier earned ₹6.1 Cr. For the full year, FY26 profit was ₹22.0 Cr (−24.1% on the year before). Why profit moved: revenue changed +143.0% on a year earlier and the margin moved −9.5 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed −15.5% and revenue +94.6%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Amal make, and is it growing? Amal Ltd reported ₹131 Cr of revenue in the Sep 2026 quarter, +143.0% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 6 years it has grown 39.2% a year on average. The last full year, FY26, came in at ₹240 Cr. The last four reported quarters add to ₹366 Cr. FY26 revenue was ₹240 Cr, +77.8% on the year before. Recent pace: the last four quarters grew +94.6% on average, against 39.2% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +96.8%, against +93.6% a year over the last 8 quarters (accelerating); profit over the last 12 months grew −23.1%, against +86.0% a year (rolling over). ## How much of every ₹100 of sales does Amal keep? Amal Ltd's operating margin was 6.5% in the Sep 2026 quarter, 9.5 percentage points lower than the same quarter a year ago. Across 7 years it has been between −9.0% and 43.0%. The latest quarter is within that range. Why the margin moved: operating margin changed −9.5 percentage points on the year while gross margin changed −14.2 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is Amal's profit turning into cash? Over the last 3 years, 175% of Amal Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹22.0 Cr of operating cash against ₹22.0 Cr of profit. After ₹9.0 Cr of spending on assets, ₹13.0 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 175% of profit came in as cash: the cash cycle got 27 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives. What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets. ## Where does Amal's cash go? Amal Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 17 days in FY26, up from −10 days in FY21. It spent ₹16.0 Cr on assets over the last 3 years. Customers take 30 days to pay, and stock sits for 25 days on average. At FY26 sales of ₹240 Cr, each day of that cycle ties up about ₹0.7 Cr, so roughly ₹11.0 Cr is tied up in the business at any time. FY26: customers took 30 days to pay and stock sat for 25 days, about 0.8 months of sales sitting as stock, for a full cycle of 17 days, longer than FY21's −10. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 25 days. Customers pay about 30 days after that. Suppliers are paid at 38 days. Together that makes the 17-day cycle. Spending on assets: ₹16.0 Cr over the last 3 years, against ₹27.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is spending about what it takes to replace what wears out, or less. Work still in progress is ₹3.0 Cr (FY26): assets paid for that are not earning yet. In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean. ## What is Amal's P/E ratio, and how does it compare with its own history? Amal Ltd's P/E is 23.8×, near the low end of its own history: it has been lower only 12% of the time. Its usual P/E (the middle reading) is 46.1×, over 5.8 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −23.6% while the price moved −19.2%. The price did better than earnings, which pushed the multiple up within its own range. Where the price move came from: over 5 years the price moved +9.3% a year; about +46.0% a year came from earnings growth and about −36.7 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Amal business getting better or worse? Amal Ltd's business is growing steadily. Revenue and profit growth have stayed positive throughout, and ROCE is steady at 35.2%. This is based on 12 quarters of 3 measures, with some gaps. Why it matters: steady growth with healthy returns is how a business compounds over time. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. This reading has some gaps: at least one line is short, or the return line is not the quarterly series, so treat it with a little more caution. ## How much does Amal earn on its capital? Amal Ltd earned a ROCE of 26% in FY26. That is up from a low of −12% in FY23. Its return on capital used (ROIC) is 17.3 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 9.2% net margin and 1.56× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 9.2% net margin × 1.56× asset turnover × 1.28× leverage (assets divided by equity) ≈ 18.4% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 29.3% − 12.0% = +17.3 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. A gap this wide means each rupee put back into the business creates more than a rupee of value. The 29.3% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 26.6%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Amal have too much debt? Amal Ltd has total debt of ₹8.0 Cr against shareholder equity of ₹76.0 Cr as of Dec 2024, so its debt is 0.11× its equity, which is very little. Year by year, that ratio went from 1.46 in FY22 to 0.34 in FY24. So the returns on this page come from the business, not from borrowed money. ## What is the Amal shareholding pattern? No group of Amal Ltd's owners changed its stake by a full percentage point over the last two years. Domestic institutions moved +0.0 points over the same period, to 0.0%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Promoters: +0.0 points over 8 quarters, to 71.3%; Domestic institutions: +0.0 points over 8 quarters, to 0.0%. ## How far is Amal from balance-sheet trouble? For Amal Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Amal rank in its industry? 41.3 out of 100, rank 26 of 30 in Speciality Chemicals, with 68% of the evidence available. Amal Ltd scores 41.3 out of 100 against the 30 companies it is compared with in Speciality Chemicals, ranking 26. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 8 + 14.7 + 10.8 + 7.8 = 41.3. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Amal compared with? Amal ranks 26 of 30 Speciality Chemicals companies on the 4-Factor Sector Score, with 41.3 out of 100. 1. [Panama Petrochem Ltd](https://www.sectoralpha.in/stocks/panama-petrochem-ltd) PANAMAPET · turning · Sector-leading setup · 96% evidence 82.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.8/35 · Revenue 45.9% · Profit 100% · Operating margin change 14 points · 88% evidence Capital efficiency 17.6/25 · ROCE 19.2% · Operating margin 22% · 100% evidence Valuation 19.7/20 · P/E 5.7× · PEG 0.18 · 100% evidence Relative strength 13.9/20 · Lead over its industry 16.3% · Lead over NIFTY 500 31.3% · 1 year 68.1% · 100% evidence · 10 of 12 weeks ahead Exact sum: 30.8 + 17.6 + 19.7 + 13.9 = 82 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Yasho Industries Ltd](https://www.sectoralpha.in/stocks/yasho-industries-ltd) YASHO · losing its lead · Most evidence points up · 78% evidence 67.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.0/35 · Revenue 54.2% · Profit 100% · Operating margin change 3 points · 100% evidence Capital efficiency 12.3/25 · ROCE 8.9% · Operating margin 21% · 100% evidence Valuation 12.7/20 · P/E 45× · PEG 1.02 · 65% evidence Relative strength 12.2/20 · Lead over its industry n/a · Lead over NIFTY 500 41.1% · 1 year 103.4% · 25% evidence · 11 of 12 weeks ahead Exact sum: 30 + 12.3 + 12.7 + 12.2 = 67.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Vikram Thermo (India) Ltd](https://www.sectoralpha.in/stocks/vikram-thermo-indialtd) breaking out · Evidence leans up · 68% evidence 64.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.8/35 · Revenue 16.9% · Profit 41.9% · Operating margin change 8 points · 83% evidence Capital efficiency 21.1/25 · ROCE 36.2% · Operating margin 48% · 95% evidence Valuation 6.6/20 · P/E 25.8× · PEG n/a · 50% evidence Relative strength 12.5/20 · Lead over its industry n/a · Lead over NIFTY 500 74.5% · 1 year n/a · 25% evidence · 12 of 12 weeks ahead Exact sum: 23.8 + 21.1 + 6.6 + 12.5 = 64 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 4. [Sunshield Chemicals Ltd](https://www.sectoralpha.in/stocks/sunshield-chemicals-ltd) SUNSHIEL · quiet · Evidence leans up · 81% evidence 63.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 12.9% · Profit 100% · Operating margin change 5 points · 88% evidence Capital efficiency 18.6/25 · ROCE 19.9% · Operating margin 16% · 100% evidence Valuation 10.8/20 · P/E 24.3× · PEG 2.21 · 100% evidence Relative strength 10.8/20 · Lead over its industry n/a · Lead over NIFTY 500 4.3% · 1 year -4% · 25% evidence · 0 of 5 weeks ahead Exact sum: 23.6 + 18.6 + 10.8 + 10.8 = 63.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Black Rose Industries Ltd](https://www.sectoralpha.in/stocks/black-rose-industries-ltd) BLACKROSE · quiet · Evidence leans up · 81% evidence 60.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 8.6% · Profit 28.6% · Operating margin change 6 points · 88% evidence Capital efficiency 16.3/25 · ROCE 18.7% · Operating margin 16% · 100% evidence Valuation 10.0/20 · P/E 17.1× · PEG 4.96 · 100% evidence Relative strength 10.9/20 · Lead over its industry n/a · Lead over NIFTY 500 4.4% · 1 year n/a · 25% evidence · 7 of 12 weeks ahead Exact sum: 23.6 + 16.3 + 10 + 10.9 = 60.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Tatva Chintan Pharma Chem Ltd](https://www.sectoralpha.in/stocks/tatva-chintan-pharma-chem-ltd) TATVA · losing its lead · Evidence leans up · 93% evidence 59.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.7/35 · Revenue 49.2% · Profit 100% · Operating margin change 1 points · 100% evidence Capital efficiency 8.5/25 · ROCE 7.2% · Operating margin 19% · 100% evidence Valuation 11.3/20 · P/E 60.2× · PEG 1.21 · 65% evidence Relative strength 11.4/20 · Lead over its industry 7.8% · Lead over NIFTY 500 23.3% · 1 year 15.6% · 100% evidence · 10 of 12 weeks ahead Exact sum: 28.7 + 8.5 + 11.3 + 11.4 = 59.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Aether Industries Ltd](https://www.sectoralpha.in/stocks/aether-industries-ltd) AETHER · leader · Evidence leans up · 90% evidence 59.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.4/35 · Revenue 30.2% · Profit 28.4% · Operating margin change 1 points · 100% evidence Capital efficiency 12.7/25 · ROCE 11.9% · Operating margin 32% · 100% evidence Valuation 9.7/20 · P/E 85.1× · PEG n/a · 50% evidence Relative strength 14.8/20 · Lead over its industry 22.3% · Lead over NIFTY 500 38.6% · 1 year 114.4% · 100% evidence · 12 of 12 weeks ahead Exact sum: 22.4 + 12.7 + 9.7 + 14.8 = 59.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Privi Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/privi-speciality-chemicals-ltd) PRIVISCL · quiet · Evidence leans up · 82% evidence 59.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.7/35 · Revenue 17.5% · Profit 44.5% · Operating margin change -1 points · 95% evidence Capital efficiency 18.5/25 · ROCE 22.3% · Operating margin 26% · 76% evidence Valuation 10.1/20 · P/E 33.7× · PEG n/a · 50% evidence Relative strength 7.1/20 · Lead over its industry -9.7% · Lead over NIFTY 500 4.2% · 1 year 10.5% · 100% evidence · 2 of 12 weeks ahead Exact sum: 23.7 + 18.5 + 10.1 + 7.1 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Fineotex Chemical Ltd](https://www.sectoralpha.in/stocks/fineotex-chemical-ltd) FCL · leader · Evidence leans up · 96% evidence 59.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.3/35 · Revenue 91.5% · Profit 41% · Operating margin change -2 points · 88% evidence Capital efficiency 13.6/25 · ROCE 18.3% · Operating margin 16% · 100% evidence Valuation 5.7/20 · P/E 46.1× · PEG 1.92 · 100% evidence Relative strength 19.5/20 · Lead over its industry 34.1% · Lead over NIFTY 500 48.9% · 1 year 62.9% · 100% evidence · 12 of 12 weeks ahead Exact sum: 20.3 + 13.6 + 5.7 + 19.5 = 59.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [DMCC Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/dmcc-speciality-chemicals-ltd) DMCC · quiet · Evidence leans up · 93% evidence 55.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.9/35 · Revenue 72.1% · Profit 34.5% · Operating margin change -6.9 points · 100% evidence Capital efficiency 8.6/25 · ROCE 14.8% · Operating margin 4.2% · 100% evidence Valuation 16.1/20 · P/E 16.9× · PEG 0.44 · 65% evidence Relative strength 7.8/20 · Lead over its industry -12.3% · Lead over NIFTY 500 0.9% · 1 year -15.5% · 100% evidence · 9 of 12 weeks ahead Exact sum: 22.9 + 8.6 + 16.1 + 7.8 = 55.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Aarti Industries Ltd](https://www.sectoralpha.in/stocks/aarti-industries-ltd) AARTIIND · quiet · Evidence leans up · 100% evidence 55.1 out of 100 Growth Capital Valuation Relative
12. [Galaxy Surfactants Ltd](https://www.sectoralpha.in/stocks/galaxy-surfactants-ltd) GALAXYSURF · leader · Evidence leans up · 81% evidence 53.7 out of 100 Growth Capital Valuation Relative
13. [Pidilite Industries Ltd](https://www.sectoralpha.in/stocks/pidilite-industries-ltd) PIDILITIND · quiet · Evidence leans up · 100% evidence 52.8 out of 100 Growth Capital Valuation Relative
14. [DIC India Ltd](https://www.sectoralpha.in/stocks/dic-india-ltd) DICIND · breaking out · Evidence leans up · 81% evidence 52.8 out of 100 Growth Capital Valuation Relative
15. [Neogen Chemicals Ltd](https://www.sectoralpha.in/stocks/neogen-chemicals-ltd) NEOGEN · leader · Evidence leans up · 90% evidence 51.7 out of 100 Growth Capital Valuation Relative
16. [Kronox Lab Sciences Ltd](https://www.sectoralpha.in/stocks/kronox-lab-sciences-ltd) KRONOX · breaking out · Evidence leans up · 74% evidence 51.6 out of 100 Growth Capital Valuation Relative
17. [Chemcon Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/chemcon-speciality-chemicals-ltd) CHEMCON · breaking out · Evidence leans up · 85% evidence 50.9 out of 100 Growth Capital Valuation Relative
18. [Grauer & Weil (India) Ltd](https://www.sectoralpha.in/stocks/grauer-weil-indialtd) GRAUWEIL · breaking out · Evidence leans down · 96% evidence 46.3 out of 100 Growth Capital Valuation Relative
19. [Paushak Ltd](https://www.sectoralpha.in/stocks/paushak-ltd) PAUSHAKLTD · losing its lead · Evidence leans down · 85% evidence 45.6 out of 100 Growth Capital Valuation Relative
20. [Alkyl Amines Chemicals Ltd](https://www.sectoralpha.in/stocks/alkyl-amines-chemicals-ltd) ALKYLAMINE · quiet · Evidence leans down · 96% evidence 45.5 out of 100 Growth Capital Valuation Relative
21. [Platinum Industries Ltd](https://www.sectoralpha.in/stocks/platinum-industries-ltd) PLATIND · turning · Evidence leans down · 81% evidence 45.5 out of 100 Growth Capital Valuation Relative
22. [Innovassynth Technologies (India) Ltd](https://www.sectoralpha.in/stocks/innovassynth-technologies-indialtd) breaking out · Too little evidence to rank firmly · 53% evidence 44.0 out of 100 Growth Capital Valuation Relative
23. [Anupam Rasayan India Ltd](https://www.sectoralpha.in/stocks/anupam-rasayan-india-ltd) ANURAS · turning · Evidence leans down · 78% evidence 43.7 out of 100 Growth Capital Valuation Relative
24. [Vinati Organics Ltd](https://www.sectoralpha.in/stocks/vinati-organics-ltd) VINATIORGA · quiet · Evidence leans down · 82% evidence 42.4 out of 100 Growth Capital Valuation Relative
25. [Amines & Plasticizers Ltd](https://www.sectoralpha.in/stocks/amines-plasticizers-ltd) AMNPLST · quiet · Evidence leans down · 81% evidence 42.3 out of 100 Growth Capital Valuation Relative
26. Amal Ltd this page AMAL · quiet · Evidence leans down · 68% evidence 41.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 8.0/35 · Revenue 96.8% · Profit -23.1% · Operating margin change -9.5 points · 100% evidence Capital efficiency 14.7/25 · ROCE 26% · Operating margin 6.5% · 100% evidence Valuation 10.8/20 · P/E 22.1× · PEG n/a · 15% evidence Relative strength 7.8/20 · Lead over its industry n/a · Lead over NIFTY 500 -9.8% · 1 year -25.5% · 25% evidence · 2 of 5 weeks ahead Exact sum: 8 + 14.7 + 10.8 + 7.8 = 41.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 27. [Transpek Industry Ltd](https://www.sectoralpha.in/stocks/transpek-industry-ltd) TRANSPEK · losing its lead · Evidence leans down · 63% evidence 38.6 out of 100 Growth Capital Valuation Relative
28. [Vishnu Chemicals Ltd](https://www.sectoralpha.in/stocks/vishnu-chemicals-ltd) VISHNU · losing its lead · Evidence leans down · 100% evidence 38.2 out of 100 Growth Capital Valuation Relative
29. [Clean Science & Technology Ltd](https://www.sectoralpha.in/stocks/clean-science-technology-ltd) CLEAN · breaking out · Evidence leans down · 85% evidence 38.1 out of 100 Growth Capital Valuation Relative
30. [Thirumalai Chemicals Ltd](https://www.sectoralpha.in/stocks/thirumalai-chemicals-ltd) TIRUMALCHM · quiet · Most evidence points down · 68% evidence 27.4 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Speciality Chemicals](https://www.sectoralpha.in/sectors/speciality-chemicals), all 30 compared on one page. ## Which companies are close to Amal in size? Amal is the 27th largest of 30 Speciality Chemicals companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Kronox Lab Sciences, Transpek Industry and Chemcon Speciality Chemicals. Just below it: DMCC Speciality Chemicals, Black Rose Industries and DIC India. ### Speciality Chemicals companies close in size

1. [Kronox Lab Sciences Ltd](https://www.sectoralpha.in/stocks/kronox-lab-sciences-ltd) ₹691 crore
2. [Transpek Industry Ltd](https://www.sectoralpha.in/stocks/transpek-industry-ltd) ₹682 crore
3. [Chemcon Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/chemcon-speciality-chemicals-ltd) ₹666 crore
4. Amal Ltd ₹658 crore
5. [DMCC Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/dmcc-speciality-chemicals-ltd) ₹634 crore
6. [Black Rose Industries Ltd](https://www.sectoralpha.in/stocks/black-rose-industries-ltd) ₹491 crore
7. [DIC India Ltd](https://www.sectoralpha.in/stocks/dic-india-ltd) ₹474 crore

[All 30 Speciality Chemicals companies, largest first](https://www.sectoralpha.in/sectors/speciality-chemicals#all-companies)

### Companies close in size in other industries

1. [R M Drip & Sprinklers Systems Ltd](https://www.sectoralpha.in/stocks/r-m-drip-sprinklers-systems-ltd) ₹661 crore · Plastics - Drip Irrigation
2. [Parth Electricals & Engineering Ltd](https://www.sectoralpha.in/stocks/parth-electricals-engineering-ltd) ₹659 crore · Electric Equipment - General
3. Amal Ltd ₹658 crore
4. [Orbit Exports Ltd](https://www.sectoralpha.in/stocks/orbit-exports-ltd) ₹658 crore · Textiles - Weaving
5. [Banganga Paper Industries Ltd](https://www.sectoralpha.in/stocks/banganga-paper-industries-ltd) ₹657 crore · Steel Products

## What else do people ask about Amal? ### What is Amal's share price today? Amal Ltd's share price is ₹574.70, −19.2% over the past year. The whole company is worth ₹709 Cr on the market. In the last 52 weeks it traded between ₹442 to ₹776; today it is 40% of the way up from the low, 14.0% below its 200-day average (as of 4 November 2026). ### What were Amal's latest quarterly results? Amal Ltd reported revenue of ₹131 Cr and net profit of ₹6.2 Cr for the Sep 2026 quarter. Revenue rose 143.0% and profit rose 1.7% compared with a year earlier. Earnings per share were ₹4.98. The operating margin was 6.5%, 9.5 percentage points lower than a year earlier (as of 4 November 2026). ### What is Amal's market cap? Amal Ltd's market capitalisation is ₹709 Cr at a share price of ₹574.70. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026). ### How is Amal performing? Amal Ltd's share price has been rising for 14 weeks. In its latest quarter, revenue rose 143.0% and profit rose 1.7% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 3 weeks running (as of 4 November 2026). ### Will Amal's share price go up? This page does not forecast Amal Ltd's share price. What it shows instead: the share price is ₹574.70, and it has been rising for 14 weeks. Its P/E of 23.8× is higher than 12% of its own last 6 years (as of 4 November 2026). ### Does Amal have too much debt? No, Amal Ltd has little debt: its debt is 0.00× its equity, and its operating profit is 36 times its interest bill. FY26 borrowings were ₹0.0 Cr against equity of ₹120 Cr. So the returns on this page come from the business, not borrowed money (as of 4 November 2026). ### Where is Amal in its business cycle? Amal Ltd's FY26 operating margin was 15.0%, against a 7-year range of −9.0% to 43.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 6.5%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026). ### What could break the Amal story? Biggest thing to watch: the price has already been rising for 14 weeks, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026). ### Is Amal a stock worth studying right now? What the numbers show: Amal Ltd's results are improving, while its P/E is near the low end of its own history over 5.8 years, higher than only 12% of past readings. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026). This is research, not advice. We’re not SEBI-registered.